Trial Profile
The Effect of Vilanterol Against Methacholine-induced Bronchoconstriction in Mild Asthmatics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone furoate
- Indications Asthma
- Focus Therapeutic Use
- 09 Oct 2018 Status changed from recruiting to completed.
- 11 Jul 2018 Primary endpoint has been met. (Change from baseline methacholine PC20 (bronchoprotection) at 30 min post-treatment) as per results published in the Annals of Allergy, Asthma and Immunology
- 11 Jul 2018 Results published in the Annals of Allergy, Asthma and Immunology